Symrise
a major flavor-and-fragrance house making an equity investment in Cellibre (US biotech) to accelerate fermented natural ingredients for flavor solutions and cosmetic actives.
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | — |
| wood-construction | ✓ | ✓ | ✓ |
Regulatorsreachnmpaepaademefdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic menthol | specialty-fine-chem | Medium | → |
| Cell factories for flavors & fragrances | food-alt-protein | Medium | → |
| Wild-harvest bioeconomy | wood-construction | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.